http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-506787-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-66
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-70
filingDate 1999-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39c877cd5f3e3d1693817ca5555b717a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ea1b420cb8f38ead140ed465124a0bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23da23cc5f6b0fd065a1d7704b76836d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c993519c4cc61aaa2920228e533f50eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7757ef2d4bf123ae90dbdd758418436c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db1c30ca5d5a6229c66afccb1eb5c16e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1b13c52d5d2891347c9170eaf8f9d55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_733dda56f04f396e6ac5918f30573d98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_365d6c008ac0e8dce16ca0477eba79ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd353bc9b009350567061c9d0ce4b4a2
publicationDate 2003-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-506787-A
titleOfInvention Trisubstituted 1,3,5-triazine derivatives having HIV replication inhibiting properties for treatment of HIV infections and preparation process thereof
abstract The use of a compound of formula (I) a N-oxide, a pharmaceutically acceptable addition salt or a stereochemically isomeric form thereof, for the manufacture of a medicine for the treatment of HIV (Human Immunodeficiency Virus) infection, wherein: A is CH, CR4 or N; n is 0,1,2,3 or 4; R1 and R2 are hydrogen, hydroxy, C1-12alkyl, C1-12alkyloxy, C1-12alkylcarbonyl, C1-12alkyloxycarbonyl, aryl, amino, mono-or di (C1-12alkyl)amino, mono-or di (C1-12alkyl) aminocarbonyl wherein each of the aforementioned C1-12alkyl groups may optionally and each individually be substituted with one or two substituents each independently selected from hydroxy, C1-6alkyloxy, hydroxy C1-6alkyloxy, carboxyl, C1-6alkyloxycarbonyl, cyano, amino, imino, aminocarbonyl, aminocarbonylamino, mono-or di (C1-6alkyl)amino, aryl and Het; or R1 and R2 taken together may form pyrrolidinyl, piperidinyl, morpholinyl, azido or mono-or di (C1-12alkyl) aminoC1-4alkylidene; R3 is hydrogen, aryl, C1-6alkylcarbonyl, C1-6alkyl, C1-6alkyloxycarbonyl, C1-6alkyl substituted with C1-6alkyloxycarbonyl; and each R4 independently is hydroxy, halo, C1-6alkyl, C1-6alkyloxy, cyano, aminocarbonyl, nitro, amino, trihalomethyl or trihalomethyloxy ; L is-X-R5 or-X-Alk-R6; wherein R5 and R6 each independently are indanyl, indolyl or phenyl; each of said indanyl, indolyl or phenyl may be substituted with one, two, three, four or five substituents each independently selected from halo, C1-6alkyl, C1-6alkyloxy, hydroxy, C1-6alkylcarbonyl, C1-6alkyloxycarbonyl, formyl, cyano, nitro, amino and trifluoromethyl; Alk is C1-4alkylene; and X is-NR3-,-NH-NH-,-N=N-,-O-,-S-,-S (=O)-or-S (=O) 2-; aryl is phenyl or phenyl substituted with one, two, three, four or five substituents each independently selected from halo, C1-6alkyl, C1-6alkyloxy, cyano, nitro and trifluoromethyl; Het is an aliphatic or aromatic heterocyclic radical; said aliphatic heterocyclic radical is selected from pyrrolidinyl, piperidinyl, homopiperidinyl, piperazinyl, morpholinyl, tetrahydrofuranyl and tetrahydrothienyl wherein each of said aliphatic heterocyclic radical may optionally be substituted with an oxo group; and said aromatic heterocyclic radical is selected from pyrrolyl, furanyl, thienyl, pyridinyl, pyrimidinyl, pyrazinyl and pyridazinyl wherein each of said aromatic heterocyclic radical may optionally be substituted with hydroxy.
priorityDate 1998-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455502157
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456462261
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457492151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 50.